Proposal of Progression Model for Intrahepatic Cholangiocarcinoma: Clinicopathologic Differences Between Hilar Type and Peripheral Type
Shinichi Aishima(Saga University), Masazumi Tsuneyoshi(Sanno Medical Center), Yunosuke Nishihara(Kyushu University), Yoshihiko Maehara(Kyushu University), Akinobu Taketomi(Hokkaido University), Yousuke Kuroda, Tomohiro Iguchi(Fukuoka Higashi Medical Center), Kenichi Taguchi
Cited by 153
Related Papers
Expression profile of class I histone deacetylases in human cancer tissues
|Oncology Reports|2007|341
Interleukin‐6/<scp>STAT</scp>3 signaling as a promising target to improve the efficacy of cancer immunotherapy
|Cancer Science|2017|295
Genome-wide Association Study Identifies TNFSF15 and POU2AF1 as Susceptibility Loci for Primary Biliary Cirrhosis in the Japanese Population
|The American Journal of Human Genetics|2012|272
Long‐term and perioperative outcomes of laparoscopic versus open liver resection for hepatocellular carcinoma with propensity score matching: a multi‐institutional Japanese study
|Journal of Hepato-Biliary-Pancreatic Sciences|2015|267
Randomized phase <scp>III</scp> study of gemcitabine, cisplatin plus S‐1 versus gemcitabine, cisplatin for advanced biliary tract cancer (<scp>KHBO1401</scp>‐ <scp>MITSUBA</scp>)
|Journal of Hepato-Biliary-Pancreatic Sciences|2022|244